Quality of life of patients with polymorbid pathology
https://doi.org/10.18699/SSMJ20210109
Abstract
Multimorbidity is an urgent problem of modern medicine, associated with a greater severity and more serious prognosis of diseases, a large number of complications, difficulty and the high cost of diagnosis and treatment. The study of the quality of life of patients with multimorbidity is necessary for the competent distribution of health resources. Aim of the study was to investigate the effect of transnozologic multimorbidity (TMM) on the components of quality of life (QoL) in patients of a therapeutic clinic. Material and methods. A total of 116 patients, men and women aged 20 to 75 years were examined at the clinic of the Federal Research Center for Fundamental and Translational Medicine in Novosibirsk. TMM was evaluated by the average number of nosologies corresponding to the three-digit classification of ICD-10. Assessment of QoL indicators was carried out using the validated questionnaire SF-36. To assess the number and severity of chronic diseases in the structure of TMM, the CIRS (Cumulative Illness Rating Scale) system was used. Results. Depending on the severity of TMM, 3 groups of patients were formed – with low (n = 42), medium (n = 52) and high TMM (n = 22). A comparative analysis of indicators of QoL, as well as TMM structure in 3 groups was carried out. A comparative analysis showed a significant decrease in the level of physical functioning (by 27 %), physical and mental health components (by 26.3 % and 15.8 %, respectively), and the integral indicator of quality of life (by 19.2 %) in patients with a high level TMM, compared with patients with low TMM. Correlation analysis confirmed the presence of a statistically significant relationship between an increase in TP and a decrease in the main indicators of QoL. Conclusion. An increase in the degree of TMM in patients is significantly associated with a decrease in the main indicators of QoL.
About the Authors
E. V. Sevostyanova
Federal Research Center of Fundamental and Translational Medicine
Russian Federation
Russian Federation
Evgeniya V. Sevostyanova, candidate of medical sciences
630117, Novosibirsk, Timakov str., 2
Yu. A. Nikolaev
Federal Research Center of Fundamental and Translational Medicine
Russian Federation
Russian Federation
Yury A. Nikolaev, doctor of medical sciences
630117, Novosibirsk, Timakov str., 2
I. M. Mitrofanov
Federal Research Center of Fundamental and Translational Medicine
Russian Federation
Russian Federation
Igor M. Mitrofanov, doctor of medical sciences
630117, Novosibirsk, Timakov str., 2
V. Ya. Polyakov
Federal Research Center of Fundamental and Translational Medicine
Russian Federation
Russian Federation
Vladimir Ya. Polyakov, doctor of medical sciences
630117, Novosibirsk, Timakov str., 2
Yu. V. Melikhova
Federal Research Center of Fundamental and Translational Medicine
Russian Federation
Russian Federation
Julia V. Melikhova
630117, Novosibirsk, Timakov str., 2
References
1. Marengoni A., Angleman S., Melis R., Mangialasche F., Karp A., Garmen A., Meinow B., Fratiglioni L. Aging with multimorbidity: a systematic review of the literature. Ageing Res Rev. 2011; 10 (4): 430–439. doi: 10.1016/j.arr.2011.03.003
2. Kim K.I., Lee J.H., Kim C.H. Impaired healthrelated quality of life in elderly women is associated with multimorbidity: results from the Korean National Health and nutrition examination survey. Gender Med. 2012; 5: 309–318. doi: 10.1016/j.genm.2012.08.001
3. Lefèvre T., d’Ivernois J.F., de Andrade V., Crozet C., Lombrail P., Gagnayre R. What do we mean by multimorbidity? An analysis of the literature on multimorbidity measures, associated factors, and impact on health services organization. Rev. Epidemiol. Sante. 2014; 62 (5): 305–314. doi: 10.1016/j.respe.2014.09.002
4. Wittenberg R. The challenge of measuring multimorbidity and its costs. Isr. J. Health Policy. 2015; 4: 1. doi: 10.1186/2045-4015-4-1
5. Belyalov F.I. Treatment of internal diseases in terms of comorbidity. Moscow: GEOTAR-Media, 2016. 544 p. [In Russian].
6. Fortin M., Bravo G., Hudon C., Lapointe L., Almirall J., Dubois M.F., Vanasse A. Relationship between multimorbidity and health-related quality of life of patients in primary care. Qual. Life Res. 2006; 15 (1): 83–91. doi: 10.1007/s11136-005-8661-z
7. Williams J.S., Egede L.E. The association between multimorbidity and quality of life, health status and functional disability. Am. J. Med. Sci. 2016; 352 (1): 45–52. doi: 10.1016/j.amjms.2016.03.004
8. Shad B., Ashouri A., Hasandokht T., Rajati F., Salari A., Naghshbandi M., Mirbolouk F. Effect of multimorbidity on quality of life in adult with cardiovascular disease: a cross-sectional study. Health Qual. Life. Out. 2017; 15 (1): 240. doi: 10.1186/s12955-0170820-8
9. Mal’chikova S.V., Maksimchuk-Kolobova N.S., Kazakovceva M.V. The effect of polymorbidity in elderly patients with atrial fibrillation on the «cost of the disease». Farmakoekonomika. Sovremennaya farmakoekonomika i farmakoepidemiologiya = Farmakoekonomika. Modern Pharmacoeconomic and Pharmacoepidemiology. 2019; 12 (3): 191–199. [In Russian]. doi: 10.17749/2070-4909.2019.12.3.191-199
10. Menotti A., Mulder I., Nissinen A., Giampaoli S., Feskens E.J., Kromhout D. Prevalence of morbidity and multimorbidity in elderly male populations and their impact on 10-year all-cause mortality: the FINE study (Finland, Italy, Netherlands, elderly). J. Clin. Epidemiol. 2001; 54 (7): 680–686. doi: 10.1016/S08954356(00)00368-1
11. Gijsen R., Hoeymans N., Schellevis F.G., Ruwaard D., Satariano W.A., van den Bos G.A. Causes and consequences of comorbidity: a review. J. Clin. Epidemiol. 2001; 54 (7): 661–674. doi: 10.1016/S08954356(00)00363-2
12. Wang L., Palmer A.J., Cocker F., Sanderson K. Multimorbidity and health-related quality of life (HRQoL) in a nationally representative population sample: implications of count versus cluster method for defining multimorbidity on HRQoL. Health Qual. Life Out. 2017; 15 (1): 7. doi: 10.1186/s12955-016-0580-x
13. de Smedt D, Clays E., Annemans L., Doyle F., Kotseva K., Pająk A., Prugger C., Jennings C., Wood D., de Bacquer D. Health related quality of life in coronary patients and its association with their cardiovascular risk profile: results from the EUROASPIRE III survey. Int. J. Cardiol. 2013; 168 (2):8 98–903. doi: 10.1016/j.ijcard.2012.10.053
14. National Guideline Centre (UK). Multimorbidity: assessment, prioritisation and management of care for people with commonly occurring multimorbidity. London: National Institute for Health and Care Excellence (UK), 2016.
15. De Souza Santos Machado V., Valadares A.L., da Costa-Paiva L.S., Moraes S.S., Pinto-Neto A.M. Multimorbidity and associated factors in Brazilian women aged 40 to 65 years: a population-based study. Menopause. 2012; 19 (5): 569–575. doi: 10.1097/gme.0b013e3182455963
16. Agborsangaya C.B., Lau D., Lahtinen M., Cooke T., Johnson J.A. Health-related quality of life and healthcare utilization in multimorbidity: results of a cross-sectional survey. Qual. Life Res. 2013; 22 (4): 791–799. doi: 10.1007/s11136-012-0214-7
17. N’Goran A.A., Deruaz-Luyet A., Haller D.M., Zeller A., Rosemann T., Streit S., Herzig L. Comparing the self-perceived quality of life of multimorbid patients and the general population using the EQ-5D-3L. PLoS One. 2017; 12: e0188499. doi: 10.1371/journal.pone.0188499
18. Amaral T.L.M., Amaral C.A., Lima N.S., Herculano P.V., Prado P.R.D., Monteiro G.T.R. GTR3. Multimorbidity, depression and quality of life among elderly people assisted in the Family Health Strategy in Senador Guiomard, Acre, Brazil. Cienc. Saude Coletiva. 2018; 23 (9): 3077–3084. doi: 10.1590/141381232018239.22532016
19. Kanesarajah J., Waller M., Whitty J.A., Mishra G.D. Multimorbidity and quality of life at midlife: A systematic review of general population studies. Maturitas. 2018; 109: 53–62. doi: 10.1016/j.maturitas.2017.12.004
20. Gu J., Chao J., Chen W., Xu H., Zhang R., He T., Deng L. Multimorbidity and health-related quality of life among the community-dwelling elderly: A longitudinal study. Arch. Gerontol. Geriatr. 2018; 74: 133–140. doi: 10.1016/j.archger.2017.10.019
21. Sum G., Salisbury C., Koh G.C., Atun R., Oldenburg B., McPake B., Vellakkal S., Lee J.T. Implications of multimorbidity patterns on health care utilisation and quality of life in middle-income countries: cross-sectional analysis. J. Glob. Health. 2019; 9 (2): 020413. doi: 10.7189/jogh.09.020413
22. de Groot V., Beckerman H., Lankhorst G.J., Bouter L.M. How to measure comorbidity: a critical review of available methods. J. Clin. Epidemiol. 2003; 56 (3): 221–229. doi: 10.1016/s0895-4356(02)00585-1
23. Sf-36 Health Survey: Manual and interpretation guide. Eds. J.Е. Ware, K.K. Snow, М. Kosinski, В. Gandek Massachusetts: The Health Institute, 2000. 23 p.
24. Novik A.A., Ionova T.I. Guide to the study of quality of life in medicine. Moscow: OLMAPRESS, 2007. 320 р. [In Russian].
25. Sevost’yanova E.V., Nikolaev Yu.A., Mitrofanov I.M., Polyakov V.Ya. Risk factors for cardiovascular disease in patients with non-alcoholic fatty liver disease with multimorbidity. Kardiovaskulyarnaya terapiya i profilaktika = Cardiovascular Therapy and Prevention. 2019; 18 (5): 74–79. [In Russian]. doi: 10.15829/1728-8800-2019-5-74-79
Review
For citations:
Sevostyanova E.V., Nikolaev Yu.A., Mitrofanov I.M., Polyakov V.Ya., Melikhova Yu.V. Quality of life of patients with polymorbid pathology. Сибирский научный медицинский журнал. 2021;41(1):91-99. (In Russ.) https://doi.org/10.18699/SSMJ20210109
Views:
655
Email this article 